Author

Joyanta K. Modak

Deakin UniversityORCID 0000-0002-0979-9504Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1 Organism:plant (other)· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

Alyssa E. BarryiD· 1 shared Brad E. SleebsiD· 1 shared Brendan S. CrabbiD· 1 shared Claudia B. G. BarnesiD· 1 shared Coralie BouletiD· 1 shared Kirsty McCanniD· 1 shared Madeline G. DansiD· 1 shared Molly Parkyn SchneideriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Alyssa E. BarryORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Aryl N-acetamide compounds exert antimalarial activity by acting as agonists of rhomboid protease PfROM8 and cation channel PfCSC1.

Coralie Boulet, Joyanta K. Modak, Natalie A. Counihan, Molly Parkyn Schneider, William Nguyen, Madeline G. Dans, Claudia B. G. Barnes, Zahra Razook, Kirsty McCann, Alyssa E. Barry, Brendan S. Crabb, Brad E. Sleebs, Tania F. de Koning‐Ward, Paul R. Gilson

This study identifies M-512 as an agonist of PfROM8 and PfCSC1, which are essential for Plasmodium falciparum growth, and shows that their dysregulation reduces parasite viability.

bioRxiv · Mar 18, 2025 · PreprintMicrobiology